Utilização de bacteriófagos ambientais no controle de biofilmes de Salmonella spp. em superfícies utilizadas na indústria de processamento e comercialização de frango de corte e derivados

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Gamma-ray dosimetric properties of conjugated polymers in solution

The effect of gamma radiation on poly{[2,5-bis(3-(N,N-diethylamino)-1-oxapropyl)-1,4-phenylene]-alt-1,4- phenylene} (PPP); poly{[2,5-bis(3-(N,N-diethylammonium bromide)-1-oxapropyl)-1,4-phenylene]-alt-1,4-phenylene} (PPP-Br); and the polymerized dye poly-1-ethyl-2-[3-(1-ethyl-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene)-1-propenyl]- 3,3-dimethyl-3H-indolium perchlorate (Poly-CyC) has been investigated. The stability and response of poly [2-methoxy- 5-(2'- ethyl-hexyloxy)-p-phenylenevinylene] (MEH-PPV) in mixed solutions have also been explored. To this end, samples with concentrations ranging from 0.005 to 0.500 mg/mL were irradiated with a 60Co gamma-ray source at room temperature, using doses up to 1 kGy, and the response was analyzed by UV-Vis spectroscopy. The obtained results reinforce the previously proposed mechanism and suggest that the effect depends on specific structural characteristics of the main chain of the polymers. Moreover, the polymerized dyes display interesting dosimetric properties. Additionally, it has been noted that, contrary to what happens in other solvents, MEH-PPV is degraded in bromoform solution. Protective effects have also been observed for bromoform+toluene mixtures (1:1 vol/vol) and solutions containing molecular dyes. - See more at: http://www.eurekaselect.com/117251/article#sthash.gHFnYvJk.dpuf

Influência dos tratamentos térmicos na microestrutura e nos micromecanismos de fratura da liga ti-6al-4v produzida por sinterização direta de metal por laser (DMLS)

Pós-graduação em Engenharia Mecânica - FEIS

Reproductive parameters of dairy goats submitted to estrus synchronization with prostaglandin F2a associated or not to hCG at estrous onset

Coodernação de Aperfeiçoamento de Pessoal de Nível Superior(CAPES)

Síntese e caracterização da cerâmica de [BaZr0,1Ce0,7Y0,1Yb0,1O3-δ] para uso como eletrólito de Células a Combustível de Cerâmicas Protônicas (PCFCs)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Lipophilicity as a determinant of binding of procaine analogs to rat alpha(3)beta(4) nicotinic acetylcholine receptor

Nicotinic acetylcholine receptors (nAChRs) have been studied in detail with regard to their interaction with therapeutic and drug addiction-related compounds. Using a structureactivity approach, we have examined the relationship among the molecular features of a set of eight para-R-substituted N,N-[(dimethylamino)ethyl] benzoate hydrochlorides, structurally related to procaine and their affinity for the a3 beta 4 nAChR heterologously expressed in KXa3 beta 4R2 cells. Affinity values (log[1/IC50]) of these compounds for the a3 beta 4 nAChR were determined by their competition with [3H]TCP binding. Log(1/IC50) values were analyzed considering different hydrophobic and electronic parameters and those related to molar refractivity. These have been experimentally determined or were taken from published literature. In accordance with literature observations, the generated cross-validated quantitative structureactivity relationship (QSAR) equations indicated a significant contribution of hydrophobic term to binding affinity of procaine analogs to the receptor and predicted affinity values for several local anesthetics (LAs) sets taken from the literature. The predicted values by using the QSAR model correlated well with the published values both for neuronal and for electroplaque nAChRs. Our work also reveals the general structure features of LAs that are important for interaction with nAChRs as well as the structural modifications that could be made to enhance binding affinity. (c) 2012 Wiley Periodicals, Inc.

Tuning the reaction products of ruthenium and ciprofloxacin for studies of DNA interactions

This work presents two potential metallo-drugs, the ionic (C17H19FN3O3)(3)[RuCl6]center dot 3H(2)O (1) and the coordination [Ru(C17H17FN3O3)(3)]center dot 4H(2)O (2) compounds, obtained by the combination of ruthenium(III) and ciprofloxacin in different synthetic conditions. The ESI MS spectrum of 1 displayed a main peak at m/z = 994.6, assigned to the gaseous phase adduct (ciprofloxacin)(3)center dot H+, while 2 featured peaks at m/z 1093.3 and 547.1 ascribed to [Ru(C17H17FN3O3)(3)center dot H+-4H(2)O](+) and [Ru(C17H17FN3O3)(3)center dot 2H(+)-4H(2)O](2+). Thermal analysis corroborated the proposed water content for both complexes. Absorption spectra of the compounds in aqueous medium are dominated by ciprofloxacin transitions in the UV region but displayed weak bands in the visible region, assigned to ligand field transitions. The cyclic voltammograms of 2 exhibited a quasi-reversible process ascribed to the Ru(II)/(III) redox pair at -0.25V (vs. SHE) while 1 displayed this process at -0.11 V, showing that the central ruthenium ion is stabilized in the (III) oxidation state by the coordination to the hard oxygen atoms of ciprofloxacin. The solubility of 1 is pH dependent (as well as free ciprofloxacin) while 2 is fully water soluble and stable under physiological pH for at least 48 h. The compounds are also stable under incubation conditions (stomach pH and 37 degrees C) without significant pH lowering. An interaction study of 2 with ct-DNA showed a value of K-b = 2.47 (+/- 0.89) x 10(4) mol(-1) L for the intrinsic binding constant.

Plasma lipases and lipid transfer proteins increase phospholipid but not free cholesterol transfer from lipid emulsion to high density lipoproteins.

Abstract Background Plasma lipases and lipid transfer proteins are involved in the generation and speciation of high density lipoproteins. In this study we have examined the influence of plasma lipases and lipid transfer protein activities on the transfer of free cholesterol (FC) and phospholipids (PL) from lipid emulsion to human, rat and mouse lipoproteins. The effect of the lipases was verified by incubation of labeled (3H-FC,14C-PL) triglyceride rich emulsion with human plasma (control, post-heparin and post-heparin plus lipase inhibitor), rat plasma (control and post-heparin) and by the injection of the labeled lipid emulsion into control and heparinized functionally hepatectomized rats. Results In vitro, the lipase enriched plasma stimulated significantly the transfer of 14C-PL from emulsion to high density lipoprotein (p<0.001) but did not modify the transfer of 3H-FC. In hepatectomized rats, heparin stimulation of intravascular lipolysis increased the plasma removal of 14C-PL and the amount of 14C-PL found in the low density lipoprotein density fraction but not in the high density lipoprotein density fraction. The in vitro and in vivo experiments showed that free cholesterol and phospholipids were transferred from lipid emulsion to plasma lipoproteins independently from each other. The incubation of human plasma, control and control plus monoclonal antibody anti-cholesteryl ester transfer protein (CETP), with 14C-PL emulsion showed that CETP increases 14C-PL transfer to human HDL, since its partial inhibition by the anti-CETP antibody reduced significantly the 14C-PL transfer (p<0.05). However, comparing the nontransgenic (no CETP activity) with the CETP transgenic mouse plasma, no effect of CETP on the 14C-PL distribution in mice lipoproteins was observed. Conclusions It is concluded that: 1-intravascular lipases stimulate phospholipid transfer protein mediated phospholipid transfer, but not free cholesterol, from triglyceride rich particles to human high density lipoproteins and rat low density lipoproteins and high density lipoproteins; 2-free cholesterol and phospholipids are transferred from triglyceride rich particles to plasma lipoproteins by distinct mechanisms, and 3 - CETP also contributes to phospholipid transfer activity in human plasma but not in transgenic mice plasma, a species which has high levels of the specific phospholipid transfer protein activity.

HEALTH PROBLEMS AWARENESS DURING TRAVEL AMONG FACULTY MEMBERS OF A LARGE UNIVERSITY IN LATIN AMERICA. PRELIMINARY REPORT

Health safety during trips is based on previous counseling, vaccination and prevention of infections, previous diseases or specific problems related to the destination. Our aim was to assess two aspects, incidence of health problems related to travel and the traveler’s awareness of health safety. To this end we phone-interviewed faculty members of a large public University, randomly selected from humanities, engineering and health schools. Out of 520 attempts, we were able to contact 67 (12.9%) and 46 (68.6%) agreed to participate in the study. There was a large male proportion (37/44, 84.1%), mature adults mostly in their forties and fifties (32/44, 72.7%), all of them with higher education, as you would expect of faculty members. Most described themselves as being sedentary or as taking occasional exercise, with only 15.9% (7/44) taking regular exercise. Preexisting diseases were reported by 15 travelers. Most trips lasted usually one week or less. Duration of the travel was related to the destination, with (12h) or longer trips being taken by 68.2% (30/44) of travelers, and the others taking shorter (3h) domestic trips. Most travelling was made by air (41/44) and only 31.8% (14/44) of the trips were motivated by leisure. Field research trips were not reported. Specific health counseling previous to travel was reported only by two (4.5%). Twenty seven of them (61.4%) reported updated immunization, but 11/30 reported unchecked immunizations. 30% (9/30) reported travel without any health insurance coverage. As a whole group, 6 (13.6%) travelers reported at least one health problem attributed to the trip. All of them were males travelling abroad. Five presented respiratory infections, such as influenza and common cold, one neurological, one orthopedic, one social and one hypertension. There were no gender differences regarding age groups, destination, type of transport, previous health counseling, leisure travel motivation or pre-existing diseases. Interestingly, the two cases of previous health counseling were made by domestic travelers. Our data clearly shows that despite a significant number of travel related health problems, these highly educated faculty members, had a low awareness of those risks, and a significant number of travels are made without prior counseling or health insurance. A counseling program conducted by a tourism and health professional must be implemented for faculty members in order to increase the awareness of travel related health problems.

Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment

Background Type 1 diabetes (T1DM) is frequently accompanied by dyslipidemia related with insulin-dependent steps of the intravascular lipoprotein metabolism. T1DM dyslipidemia may predispose to precocious cardiovascular disease and the lipid status in T1DM under intensive insulin treatment has not been sufficiently explored. The aim was to investigate the plasma lipids and the metabolism of LDL and HDL in insulin-treated T1DM patients with high glycemic levels. Methods Sixteen male patients with T1DM (26 ± 7 yrs) with glycated hemoglobin >7%, and 15 control subjects (28 ± 6 yrs) were injected with a lipid nanoemulsion (LDE) resembling LDL and labeled with 14C-cholesteryl ester and 3H-free-cholesterol for determination of fractional clearance rates (FCR, in h-1) and cholesterol esterification kinetics. Transfer of labeled lipids from LDE to HDL was assayed in vitro. Results LDL-cholesterol (83 ± 15 vs 100 ± 29 mg/dl, p=0.08) tended to be lower in T1DM than in controls; HDL-cholesterol and triglycerides were equal. LDE marker 14C-cholesteryl ester was removed faster from plasma in T1DM patients than in controls (FCR=0.059 ± 0.022 vs 0.039 ± 0.022h-1, p=0.019), which may account for their lower LDL-cholesterol levels. Cholesterol esterification kinetics and transfer of non-esterified and esterified cholesterol, phospholipids and triglycerides from LDE to HDL were also equal. Conclusion T1DM patients under intensive insulin treatment but with poor glycemic control had lower LDL-cholesterol with higher LDE plasma clearance, indicating that LDL plasma removal was even more efficient than in controls. Furthermore, HDL-cholesterol and triglycerides, cholesterol esterification and transfer of lipids to HDL, an important step in reverse cholesterol transport, were all normal. Coexistence of high glycemia levels with normal intravascular lipid metabolism may be related to differences in exogenous insulin bioavailabity and different insulin mechanisms of action on glucose and lipids. Those findings may have important implications for prevention of macrovascular disease by intensive insulin treatment.

Changes in prolactin secretion in the short- and long-term after adrenalectomy

OBJECTIVE: To evaluate the modulation of the hypothalamus-pituitary-adrenal axis (HPA) on prolactin secretion in rats after adrenalectomy (ADX). MATERIALS AND METHODS: Plasma corticosterone, ACTH, and prolactin concentrations were measured by radioimmunoassay in rats after bilateral ADX in the short- (3 hours and 1day) and long-term (3, 7, and 14 days). RESULTS: Animals that underwent ADX showed undetectable corticosterone levels and a triphasic ACTH response with a transient increase (3h), a decrease (1d), and further increase in the long-term after ADX. Sham animals showed a marked increase in corticosterone and ACTH levels three hours after surgery, with a decrease to basal levels thereafter. Plasma prolactin levels were not changed after ADX. CONCLUSION: There are different points of equilibrium in the HPA axis after the glucocorticoid negative feedback is removed. Prolactin plasma secretion is not altered in the short or long- term after ADX, suggesting that the peptidergic neurons essential for prolactin release are not activated after ADX.

Ruolo dell'Enantiomero (R)-9-HSA nel controllo della proliferazione in una linea di Adenocarcinoma del Colon umano

9-hydroxystearic acid (9-HSA) is an endogenous lipoperoxidation product and its administration to HT29, a colon adenocarcinoma cell line, induced a proliferative arrest in G0/G1 phase mediated by a direct activation of the p21WAF1 gene, bypassing p53. We have previously shown that 9-HSA controls cell growth and differentiation by inhibiting histone deacetylase 1 (HDAC1) activity, showing interesting features as a new anticancer drug. The interaction of 9-HSA with the catalytic site of the 3D model has been tested with a docking procedure: noticeably, when interacting with the site, the (R)-9-enantiomer is more stable than the (S) one. Thus, in this study, (R)- and (S)-9-HSA were synthesized and their biological activity tested in HT29 cells. At the concentration of 50 M (R)-9-HSA showed a stronger antiproliferative effect than the (S) isomer, as indicated by the growth arrest in G0/G1. The inhibitory effect of (S)-9-HSA on HDAC1, HDAC2 and HDAC3 activity was less effective than that of the (R)-9-HSA in vitro, and the inhibitory activity of both the (R)- and the (S)-9-HSA isomer, was higher on HDAC1 compared to HDAC2 and HDAC3, thus demonstrating the stereospecific and selective interaction of 9-HSA with HDAC1. In addition, histone hyperacetylation caused by 9-HSA treatment was examined by an innovative HPLC/ESI/MS method. Analysis on histones isolated from control and treated HT29 confirmed the higher potency of (R)-9-HSA compared to (S)-9-HSA, severely affecting H2A-2 and H4 acetylation. On the other side, it seemed of interest to determine whether the G0/G1 arrest of HT29 cell proliferation could be bypassed by the stimulation with the growth factor EGF. Our results showed that 9-HSA-treated cells were not only prevented from proliferating, but also showed a decreased [3H]thymidine incorporation after EGF stimulation. In this condition, HT29 cells expressed very low levels of cyclin D1, that didn’t colocalize with HDAC1. These results suggested that the cyclin D1/HDAC1 complex is required for proliferation. Furthermore, in the effort of understanding the possible mechanisms of this effect, we have analyzed the degree of internalization of the EGF/EGFR complex and its interactions with HDAC1. EGF/EGFR/HDAC1 complex quantitatively increases in 9-HSA-treated cells but not in serum starved cells after EGF stimulation. Our data suggested that 9-HSA interaction with the catalytic site of the HDAC1 disrupts the HDAC1/cyclin D1 complex and favors EGF/EGFR recruitment by HDAC1, thus enhancing 9-HSA antiproliferative effects. In conclusion 9-HSA is a promising HDAC inhibitor with high selectivity and specificity, capable of inducing cell cycle arrest and histone hyperacetylation, but also able to modulate HDAC1 protein interaction. All these aspects may contribute to the potency of this new antitumor agent.

Molecular analysis of Sigma-1 receptor modulation of the dopamine transporter

Sigma (σ) receptors are well established as a non-opioid, non-phencyclidine, and haloperidol-sensitive receptor family with its own binding profile and a characteristic distribution in the central nervous system (CNS) as well as in endocrine, immune, and some peripheral tissues. Two σ receptors subtypes, termed σ1 and σ2, have been pharmacologically characterized, but, to date, only the σ1 has also been cloned. Activation of σ1 receptors alter several neurotransmitter systems and dopamine (DA) neurotrasmission has been often shown to constitute an important target of σ receptors in different experimental models; however the exact role of σ1 receptor in dopaminergic neurotransmission remains unclear. The DA transporter (DAT) modulates the spatial and temporal aspects of dopaminergic synaptic transmission and interprer the primary mechanism by wich dopaminergic neurons terminate the signal transmission. For this reason present studies have been focused in understanding whether, in cell models, the human subtype of σ1 (hσ1) receptor is able to directly modulate the human DA transporter (hDAT). In the first part of this thesis, HEK-293 and SH-SY5Y cells were permanently transfected with the hσ1 receptor. Subsequently, they were transfected with another plasmid for transiently expressing the hDAT. The hDAT activity was estimated using the described [3H]DA uptake assay and the effects of σ ligands were evaluated by measuring the uptaken [3H]DA after treating the cells with known σ agonists and antagonists. Results illustrated in this thesis demonstrate that activation of overexpressed hσ1 receptors by (+)-pentazocine, the σ1 agonist prototype, determines an increase of 40% of the extracellular [3H]DA uptake, in comparison to non-treated controls and the σ1 antagonists BD-1047 and NE-100 prevent the positive effect of (+)-pentazocine on DA reuptake DA is likely to be considered a neurotoxic molecule. In fact, when levels of intracellular DA abnormally invrease, vescicles can’t sequester the DA which is metabolized by MAO (A and B) and COMT with consequent overproduction of oxygen reactive species and toxic catabolites. Stress induced by these molecules leads cells to death. Thus, for the second part of this thesis, experiments have been performed in order to investigate functional alterations caused by the (+)-pentazocine-mediated increase of DA uptake; particularly it has been investigated if the increase of intracellular [DA] could affect cells viability. Results obtained from this study demonstrate that (+)-pentazocine alone increases DA cell toxicity in a concentration-dependent manner only in cells co-expressing hσ1 and hDAT and σ1 antagonists are able to revert the (+)-pentazocine-induced increase of cell susceptibility to DA toxicity. In the last part of this thesis, the functional cross-talking between hσ1 receptor and hDAT has been further investigated using confocal microscopy. From the acquired data it could be suggested that, following exposure to (+)-pentazocine, the hσ1 receptors massively translocate towards the plasma membrane and colocalize with the hDATs. However, any physical interaction between the two proteins remains to be proved. In conclusion, the presented study shows for the first time that, in cell models, hσ1 receptors directly modulate the hDAT activity. Facilitation of DA uptake induced by (+)-pentazocine is reflected on the increased cell susceptibility to DA toxicity; these effects are prevented by σ1 selective antagonists. Since numerous compounds, including several drugs of abuse, bind to σ1 receptors and activating them could facilitate the damage of dopaminergic neurons, the reported protective effect showed by σ1 antagonists would represent the pharmacological basis to test these compounds in experimental models of dopaminergic neurodegenerative diseases (i.e. Parkinson’s Disease).

Thiete und Bisthiete in der Heterocyclensynthese

Die vorliegende Arbeit beschäftigt sich mit der Synthese arenoanellierter Naphthothiete und Benzobisthiete, sowie mit der Umsetzung der aus diesen Thieten thermisch generierbaren Valenzisomeren (Thiochinonmethide). Diese Thiochinonmethide sind hochreaktive Diensysteme, die mit zahlreichen Dienophilen (homo- und hetero-Doppel- und Dreifachbindungssysteme) nach Diels-Alder abreagieren, die dabei entstehenden S-Heterocyclen können im Sechsring noch weitere Heteroatome (N, P, O, S) enthalten. Daraus resultiert ein großes Potential der Arenothiete zur Synthese neuer Thioheterocyclen. Durch die erstmals gelungene Synthese der beiden Benzobisthiete 2H,3H-Benzo[1,2-b:4,3-b']bisthiet und 1H,4H-Benzo[2,1-b:3,4-b']bisthiet mit gewinkelter Anellierungsgeometrie hat das synthetische Spektrum der aus Arenothieten darstellbaren Thioheterocyclen nochmal eine deutliche Erweiterung erfahren.

Die Darstellung der Arenothiete erfolgt in einer mehrstufigen Synthese, in deren finalem Schritt sie mittels Blitz-Vakuum-Pyrolyse aus Arylhydroxymethylthiolen gebildet werden, dabei wird das Edukt mittels molekularer Strömung in den "Reaktor" eingebracht. Da die Arylhydroxymethylthiole in der Regel nur eine sehr geringe Flüchtigkeit haben, waren die Arenothiete meist nur in geringen Mengen darstellbar. Daher wurde in dieser Arbeit sowohl die Synthese neuer Arenothiete (gewinkelte Benzobisthiete) als auch eine Optimierung der bisherigen Synthesemethode angestrebt; diese erfolgt bevorzugt durch Variation der Pyrolyseedukte in Richtung zu potentiell höherflüchtigen Verbindungen.

Im Rahmen dieser Versuche war die Darstellung zweier Arenothiete ausgehend von cyclischen O,S-Acetalen als alternative Pyrolysevorstufen erfolgreich.

Ein besonderes Interesse speziell an Benzobisthieten begründet sich in ihrer generellen Fähigkeit zum Aufbau von bandartigen Strukturen durch Oligo- und Poly-Diels-Alder-Reaktionen. Durch die Synthese einiger Modellverbindungen konnte ihre prinzipielle Eignung zum Aufbau von Bandstrukturen auch für die beiden Benzobisthiete belegt werden.

Synthese, 18 F-Markierung, 11 C-Markierung und Evaluierung Hydantoin-substituierter Indolcarbonsäuren zur Visualisierung des NMDA-Rezeptorstatus mittels der Positronen-Emissions-Tomographie (PET)

Der N-methyl-D-aspartat-Rezeptor (NMDA), als Vertreter ionotroper Glutamat-Rezeptoren, ist essentiell für physiologische Lern- und Gedächtnisvorgänge und eine krankhafte Überaktivierung wird als potentielle Ursache für eine Reihe von akuten und chronischen neurodegenerativen Erkrankungen angesehen. Hierbei sind für die akuten Erkrankungen vor allem der Schlaganfall und für die chronischen Erkrankungen Morbus Parkinson sowie die Alzheimer´sche Demenz zu nennen. Durch seine einzigartige spannungsabhängige Mg2+-Blockade und der Notwendigkeit der gleichzeitigen Anwesenheit der endogenen Liganden Glutamat und Glycin zur Rezeptoraktivierung, stellt dieser Rezeptorkomplex daher ein sehr interessantes molekulares Target dar. NMDA-Rezeptor-Antagonisten der Glycin-Bindungsstelle und der verschiedenen allosterischen Bindungsstellen könnten als Neuroprotektiva bei den verschiedenen Krankheiten eine symptomatische Verbesserung bewirken und zur Therapie eingesetzt werden. Eine visuelle Darstellung des Rezeptors im Rahmen von Vorsorgeuntersuchungen ist jedoch derzeit nicht möglich. Zur Visualisierung dieser Prozesse mittels der Positronen-Emissions-Tomographie (PET) wurden basierend auf einer Hydantoin-substituierten Indol-2-carbonsäure als Leitstruktur, im Rahmen dieser Arbeit Fluorethoxy- und Methoxy-substituierte Derivate dargestellt und in pharmazeutischen und radiopharmazeutischen Studien evaluiert. Dazu wurde die Affinität und Spezifität zum Rezeptor in einem [3H]MDL-105,519 Rezeptorbindungsassay und die Lipophilie als Parameter für die Hirngängigkeit ermittelt. Anhand dieser Resultate wurden geeignete Markierungsvorläufer synthetisiert, welche eine phenolische Hydroxylfunktion besitzen und eine radioaktive Markierung mit den sekundären Markierungsvorläufern 2-[18F]Fluorethyltosylat ([18F]FETos) und [11C]Methyliodid ([11C]CH3I) ermöglichen. Unter Verwendung von 4,6-Dichlor-3-((3-(4-hydroxyphenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure wurde in einer Einstufenreaktion mit [18F]FETos die Zielverbindung 4,6-Dichlor-3-((3-(4-(2-[18F]fluorethoxy)phenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure in radiochemischen Ausbeuten von 6 % erhalten. Daher wurde eine alternative Markierung des Ethylester-geschützten Derivates 4,6-Dichlor-3-((3-(4-hydroxyphenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäureethylester in einer Zweistufensynthese mit [18F]FETos und [11C]CH3I untersucht. Unter Verwendung dieser Strategie wurden unter optimierten Bedingungen 4,6-Dichlor-3-((3-4-(2-[18F]fluorethoxy)phenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäureethylester und 4,6-Dichlor-3-((3-(4-[11C]methoxy-phenyl)-2,4-dioxoimidazolidin-1-yl)-methyl)-indol-2-carbonsäureethylester in radiochemischen Ausbeuten von 27 – 38 % erhalten. Die anschließende Entfernung der Schutzgruppe führte unter Bildung von Neben- und Zersetzungsreaktionen zu 4,6-Dichlor-3-((3-(4-(2-[18F]fluorethoxy)-phenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure und 4,6-Dichlor-3-((3-(4-[11C]methoxyphenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure in radiochemischen Gesamtausbeuten von 5 – 7 %. Die Überprüfung des biochemischen Konzepts in vivo durch µ-PET-Studien und durch autoradiographische Experimente an Rattenhirnschnitten, deuten auf eine niedrige in vivo-Aktivität hin, welche sich auf eine nicht ausreichende Passage der Blut-Hirn-Schranke zurückführen lässt.